Learning Objectives:

  1. Discuss the various treatment strategies in consideration of various challenging presentations of HCC


  1. Understand the complexities of molecular understanding, testing, and management of intrahepatic cholangiocarcinoma


  3.  Delve into further depth regarding decisions between different liver directed modalities in hepatobiliary tumors, particularly in context of how this fits in with neoadjuvant/adjuvant systemic therapies.


Session date: 
05/14/2021 - 7:00am to 8:00am CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Anjana Pillai, MD: Chih-Yi "Andy" Liao, MD; Osman Ahmed, MD: